A founder-held U.S. AI + biometrics patent (US 12,091,041 B2). Frontier and on-device models, deployed inside HIPAA-aware operations. No slideware, no proof-of-concept theater, only AI running in production.
A founder-patented AI + biometrics stack — attribution, automation, and engineering deployed inside HIPAA-eligible systems, not bolted on after the fact.
HIPAA-aware AI, deployed inside the systems that actually produce revenue.
PHI-aware by default, human-in-the-loop by design.
PHI-aware data brokering across SFTP, HL7, and FHIR. BAAs are in place before any data moves.
Vector store and de-identified RAG corpus, with provenance metadata required on every record.
Frontier-model orchestration with confidence and citation gates applied inline.
Mandatory human-in-the-loop, with licensed-clinician sign-off on any YMYL output.
CMS, API, and channel publish with a full audit log and a rollback path.
Each runs in production with PHI, human review, and BAA-backed deployment.
Conversational capture of history, insurance, and intent; routes the clinical path; answers in English or Spanish; human review on every case.
ExploreStructured extraction from clinical notes, automated packet assembly, payer-submission routing, and clinician override on every decision.
ExploreAmbient scribe plus structured SOAP synthesis with clinician sign-off; nothing unverified enters the record.
ExploreFirst-party data stitching, server-side conversions, AI creative prediction, and payer-mix-aware budget allocation.
ExploreQuantized models on clinician devices where PHI cannot leave the machine; traces to our founder's U.S. AI patent.
ExploreNative Spanish generation with cultural adaptation, not machine translation; powers hreflang and dual-schema for Hispanic-market acquisition.
ExploreOpen any practice for deliverables, staffing, and the measured outcome.
Production-grade AI inside revenue systems: intake, prior-auth automation, clinical docs, attribution. Human-in-the-loop, BAA-backed.
ExploreFirst-party data, server-side attribution, AI creative testing, conversion-grade landing pages, CRM and sales-ops to a closed-loop number.
ExploreSeventeen-phase architecture, pillar-spoke content, entity-rich schema, AI Overview citations across ChatGPT, Gemini, Claude, Perplexity.
ExploreAdmissions engineering, payer-mix optimization, clinical brand, multi-state expansion; 42 CFR Part 2 compliant.
ExploreDiligence-grade brand, provider-acquisition funnels, reimbursement-aware go-to-market, category positioning, investor narrative.
ExploreNative Spanish content engineering (not machine translation), hreflang and dual-schema, culturally-adapted creative, Hispanic patient funnels.
Explore"We did not pivot to AI. Our founder filed a U.S. AI patent and has applied statistical analysis and machine learning to healthcare data across the SPSS, TensorFlow and PyTorch eras, with regression work going back to the early 2000s."
210 Digital Marketing runs production AI inside HIPAA-covered healthcare operations, including patient intake automation, prior-authorization workflow, clinical documentation assist, attribution intelligence, on-device PHI inference, and a bilingual content engine. Each runs with human-in-the-loop review and BAA-backed deployment.
Yes. Our founder holds U.S. AI patent US 12,091,041 B2 covering AI and biometric signal interpretation, filed in 2021 and granted in 2024. It formalized statistical and machine-learning work on healthcare data across the SPSS, TensorFlow, and PyTorch eras, with regression analysis going back to the early 2000s.
Business Associate Agreements are signed before any protected health information moves. We run on-device inference where PHI cannot leave the machine, keep full audit logging on every model call, and require human-in-the-loop review on every AI workflow touching clinical content. We also support 42 CFR Part 2 operations for substance use disorder and behavioral health providers.
On-device inference runs a quantized AI model locally on a clinician device, so protected health information never leaves the machine. It matters for highest-sensitivity PHI workflows, offline clinical settings, bandwidth-constrained deployments, and jurisdiction-specific data-residency requirements. The capability traces directly to our founder's U.S. AI patent (filed 2021, issued 2024).
AI is the engineering layer beneath every practice we deliver, not a bolt-on service line. It is backed by a founder-held USPTO AI patent and senior-only delivery by 10+ year healthcare operators, with no offshore content factory.
Senior-only delivery. HIPAA-aware AI. Bilingual EN-ES. Idaho.
Book a Strategic Intake